Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment

The aim of this study was to assess the prognostic and predictive value of an untargeted assessment of tumor fractions in the plasma of metastatic breast cancer patients and to compare circulating tumor DNA (ctDNA) with circulating tumor cells (CTC) and conventional tumor markers. In metastatic brea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Christoph Suppan, Iva Brcic, Verena Tiran, Hannah D Mueller, Florian Posch, Martina Auer, Erkan Ercan, Peter Ulz, Richard J Cote, Ram H Datar, Nadia Dandachi, Ellen Heitzer, Marija Balic
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2019-08-01
Serija:Cancers
Teme:
metastatic breast cancer (MBC)
circulating tumor cells (CTCs)
cell free circulating tumor DNA (ctDNA)
mFAST-SeqS
prognosis
treatment response
Online pristup:https://www.mdpi.com/2072-6694/11/8/1171
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items